Comparing transcriptional, metabolic, and functional signatures of intra-tumoral CD8+ T lymphocytes, based on different expression levels of PD-1, Thommen et al. [82] found that CD8+ T cells expressing the highest levels of PD-1 displayed the strongest reactivity against tumor cells. This evidence concerns the gene CD8A and neoplasm.